SC 13G Filing

Company

Beam Therapeutics Inc.

Filed

September 22, 2023

Accession Number

0000908834-23-000114

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →